Search
for
Sort by
Research 181–210 of 1000+
- Cancer-Related Alopecia: From Etiologies to Global Management
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Nanomaterial-Based Therapy for Wound Healing
- Smart Microneedles for Therapy and Diagnosis
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Cutaneous toxicities of new treatments for melanoma
- A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Metformin and Malignant Tumors: Not Over the Hill
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Amphiregulin in Fibrotic Diseases and Cancer
- A Kaleidoscope of Keratin Gene Expression and the Mosaic of Its Regulatory Mechanisms
- Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Advances and Perspectives on Bioelectronic and Atomic Nanogenerators for Anticancer Therapy
- Drug-induced scarring and permanent alopecia
- Dermatologic Adverse Events from Cancer Treatments
- Protein Immobilization on Bacterial Cellulose for Biomedical Application
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Therapeutic potential of Lawsonia inermis Linn: a comprehensive overview
- Engineered exosomes in dermatology: Design strategies, functional advantages, and therapeutic translation
- The roadmap of cold atmospheric plasma for chronic diseases